RE:RE:RE:RE:WOULD BE NICEI understand your point Lithlover, but since Tripp has started for the first time to talk about fair valuation in his last presentation (in terms of billions), I started to think that it could be a possibility. Lots of small biotechs need the firepower of major players to launch disruptive products. They are not rolling on flows of money like Stagezero is atm though. Anything goes for me! We would not be bought at discount after 15 years of work and research and patents lol.
LithLover wrote: Agreed Been here too many years and put up with too much to be bought out early . I want to see dollars and nasdaq before those conversations happen and hopefully by then Tripp has marketed the heck out of this company
Str8Shuter wrote: Personally, as a long-term shareholder I would NOT want any buyout deal until SZLS has grown by leaps and bounds organically with Aristotle becoming a recognized name in the liquid biopsy space. Otherwise, retail investors will likely only get squeezed out of the picture way too early. Hopefully a buyout doesn't happen until the SP has reached
tens of dollars trading on NASDAQ. But that's just me. :-)
GLTA!
RelevantStock wrote: capebretongirl wrote: To see a strong close followed by a Halt at 0940 tomorrow a.m. with news to follow...... that would be momentum.
or crazier scenario: halt + buyout news haha. Why not?!.. If I wanted to buy Stagezero, I'd probably do it before the Aristotle launch, that I'd want to market in my own way.